Bahar Artim-Esen
Bahar Artim-Esen is an expert in Rheumatology at Istanbul University (Turkey). As of October 2026, ScienceLeadR ranks Bahar Artim-Esen in the top 1% of experts in Turkey for Autoimmune Diseases. Bahar Artim-Esen has authored 186 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 548 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Immunology - Public Health - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 186
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Association between serum transaminase elevations and clinical course in patients with familial Mediterranean fever. PMID 42886599 — genes, hepatitis, alcoholic, serum, colchicine, familial mediterranean fever, transaminases, liver, amyloidosis, diagnosis, therapeutics, hepatitis | Clin Exp Rheumatol | 2026 | 0 |
| Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis. PMID 42808274 — serum, galectins, enzyme-linked immunosorbent assay, lupus nephritis, biopsy, biomarkers, lupus erythematosus, systemic, antiphospholipid syndrome, nephritis | Lupus | 2026 | 0 |
| Evaluation of echocardiographic features and cardiac biomarkers in patients with AA amyloidosis: a retrospective comparative study with patients with al amyloidosis and hypertrophic cardiomyopathy. PMID 42696049 — rheumatology, mortality, troponin, biomarkers, cardiomyopathy, hypertrophic, amyloidosis, immunoglobulin light-chain amyloidosis, cardiomyopathies | Rheumatol Int | 2026 | 0 |
| Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry"). PMID 42690699 — registries, antibodies, antiphospholipid, classification, lupus erythematosus, systemic, antiphospholipid syndrome, lupus coagulation inhibitor, thrombosis | Lupus | 2026 | 0 |
| Clinical characteristics, organ damage and survival in idiopathic inflammatory myopathies: a long-term retrospective cohort study. PMID 42667319 — muscular diseases, rheumatology, lung, phenotype, cohort studies, myositis, lung diseases | Rheumatol Int | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
LeadR Networks
Main global connection map